drugset / Trial / NCT03017430
Pregabalin for Opiate Withdrawal Syndrome
RandomizedParallel-groupSingle-blindTreatment
Summary
It is a single blind randomized symptom triggered study to assess efficacy and safety of pregablin combined with the symptom triggered treatment for opiate withdrawal syndrome vs. clonidne with the same with the symptom triggered treatment for opiate withdrawal syndrome.
Timeline
- Start
- 2014-01
- Primary completion
- 2019-12
- Completion
- 2019-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Clonidine | Other / unclassified | 600 ug | — |
| Subject | Pregabalin | Small molecule | 600 mg | — |
| Background | Doxylamin | Unknown | 30 mg | — |
| Background | Ketorolac | Other / unclassified | — | — |
| Background | Loperamide | Small molecule | — | — |
| Background | Metoclopramide | Small molecule | — | — |
| Background | Nefazolin | Unknown | — | — |
| Background | Phenazepam | Small molecule | — | — |